AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: GADE R MUHLEMAN D BLAKE H MACMURRAY J JOHNSON P VERDE R SAUCIER G COMINGS DE
Citation: R. Gade et al., CORRELATION OF LENGTH OF VNTR ALLELES AT THE X-LINKED MAOA GENE AND PHENOTYPIC EFFECT IN TOURETTE-SYNDROME AND DRUG-ABUSE, Molecular psychiatry, 3(1), 1998, pp. 50-60

Authors: COMINGS D GADEANDAVOLU R GONZALEZ N WU S MUHLEMAN D BLAKE H DIETZ G SAUCIER G MACMURRAY J
Citation: D. Comings et al., MULTIPLE ADDITIVE ASSOCIATIONS - A TECHNIQUE FOR THE IDENTIFICATION OF GENES IN POLYGENIC DISORDERS, American journal of medical genetics, 81(6), 1998, pp. 489-489

Authors: MACMURRAY J WU S MUHLEMAN D GADEANDAVOLU R BLAKE H PETERS W JOHNSON JP SAUCIER G COMINGS DE
Citation: J. Macmurray et al., ASSOCIATIONS BETWEEN THE GAMMA-INTERFERON GENE (IFNG3), ASTHENIA, ANDOBESITY, American journal of medical genetics, 81(6), 1998, pp. 524-524

Authors: JOHNSON JP DIETZ G GADEANDAVOLU R BLAKE H MUHLEMAN D SAUCIER G MACMURRAY J COMINGS DE
Citation: Jp. Johnson et al., ASSOCIATION OF ENDOPEPTIDASE (CD10NE) DINUCLEOTIDE REPEAT POLYMORPHISM WITH ANXIETY, DEPRESSION, AND P300 AMPLITUDE, American journal of medical genetics, 81(6), 1998, pp. 524-524

Authors: COMINGS D WU S MUHLEMAN D
Citation: D. Comings et al., ANDROGEN RECEPTOR GENE, CONDUCT, AND OPPOSITIONAL DEFIANT DISORDER, American journal of medical genetics, 81(6), 1998, pp. 549-550

Authors: BLAKE H MACMURRAY J GADEANDAVOLU R WU S MUHLEMAN D DIETZ G JOHNSON JP SAUCIER G COMINGS DE
Citation: H. Blake et al., GENDER DIFFERENCES IN APOE-ASSOCIATED BRAIN WEIGHTS OF ALZHEIMERS-DISEASE CASES, American journal of medical genetics, 81(6), 1998, pp. 554-554

Authors: GADEANDAVOLU R MACMURRAY JP BLAKE H MUHLEMAN D TOURTELLOTTE W COMINGS DE
Citation: R. Gadeandavolu et al., ASSOCIATION BETWEEN THE GAMMA-AMINOBUTYRIC-ACID A(3) RECEPTOR GENE AND MULTIPLE-SCLEROSIS, Archives of neurology, 55(4), 1998, pp. 513-516

Authors: COMINGS DE MUHLEMAN D GADE R JOHNSON P VERDE R SAUCIER G MACMURRAY J
Citation: De. Comings et al., CANNABINOID RECEPTOR GENE (CNR1) - ASSOCIATION WITH IV DRUG-USE, Molecular psychiatry, 2(2), 1997, pp. 161-168

Authors: JOHNSON JP MUHLEMAN D MACMURRAY J GADE R VERDE R ASK M KELLEY J COMINGS DE
Citation: Jp. Johnson et al., ASSOCIATION BETWEEN THE CANNABINOID RECEPTOR GENE (CNR1) AND THE P300EVENT-RELATED POTENTIAL, Molecular psychiatry, 2(2), 1997, pp. 169-171

Authors: COMINGS DE GADE R WU S CHIU C DIETZ G MUHLEMAN D SAUCIER G FERRY L ROSENTHAL RJ LESIEUR HR RUGLE LJ MACMURRAY P
Citation: De. Comings et al., STUDIES OF THE POTENTIAL ROLE OF THE DOPAMINE D-1 RECEPTOR GENE IN ADDICTIVE BEHAVIORS, Molecular psychiatry, 2(1), 1997, pp. 44-56

Authors: BLAKE H GADE R MACMURRAY J MUHLEMAN D COMINGS D
Citation: H. Blake et al., GENDER DIFFERENCES IN PRESENILIN-1 GENE ASSOCIATIONS WITH MULTIPLE-SCLEROSIS, American journal of medical genetics, 74(6), 1997, pp. 643-643

Authors: MACMURRAY J GADE R BLAKE H MUHLEMAN D COMINGS D
Citation: J. Macmurray et al., CONFOUNDING PRESENILIN-1 GENE EFFECT BETWEEN ALZHEIMERS-DISEASE AND SMOKING, American journal of medical genetics, 74(6), 1997, pp. 655-655

Authors: COMINGS DE GADE R MACMURRAY JP MUHLEMAN D PETERS WR
Citation: De. Comings et al., GENETIC-VARIANTS OF THE HUMAN OBESITY (OB) GENE - ASSOCIATION WITH BODY-MASS INDEX IN YOUNG-WOMEN, PSYCHIATRIC-SYMPTOMS, AND INTERACTION WITH THE DOPAMINE D-2 RECEPTOR (DRD2) GENE, Molecular psychiatry, 1(4), 1996, pp. 325-335

Authors: COMINGS DE GADE R MUHLEMAN D CHIU C WU SJ TO M SPENCE M DIETZ G WINNDEEN E ROSENTHAL RJ LESIEUR HR RUGLE L SVERD J FERRY L JOHNSON JP MACMURRAY JP
Citation: De. Comings et al., EXON AND INTRON VARIANTS IN THE HUMAN TRYPTOPHAN 2,3-DIOXYGENASE GENE- POTENTIAL ASSOCIATION WITH TOURETTE SYNDROME, SUBSTANCE-ABUSE AND OTHER DISORDERS, Pharmacogenetics, 6(4), 1996, pp. 307-318

Authors: COMINGS DE ROSENTHAL RJ LESIEUR HR RUGLE LJ MUHLEMAN D CHIU C DIETZ G GADE R
Citation: De. Comings et al., A STUDY OF THE DOPAMINE D-2 RECEPTOR GENE IN PATHOLOGICAL GAMBLING, Pharmacogenetics, 6(3), 1996, pp. 223-234

Authors: COMINGS DE FERRY L BRADSHAWROBINSON S BURCHETTE R CHIU C MUHLEMAN D
Citation: De. Comings et al., THE DOPAMINE D-2 RECEPTOR (DRD2) GENE - A GENETIC RISK FACTOR IN SMOKING, Pharmacogenetics, 6(1), 1996, pp. 73-79

Authors: COMINGS DE WU SJ CHIU C MUHLEMAN D SVERD J
Citation: De. Comings et al., STUDIES OF THE C-HARVEY-RAS GENE IN PSYCHIATRIC-DISORDERS, Psychiatry research, 63(1), 1996, pp. 25-32

Authors: COMINGS DE WU S CHIU C RING RH GADE R AHN C MACMURRAY JP DIETZ G MUHLEMAN D
Citation: De. Comings et al., POLYGENIC INHERITANCE OF TOURETTE SYNDROME, STUTTERING, ATTENTION-DEFICIT HYPERACTIVITY, CONDUCT, AND OPPOSITIONAL DEFIANT DISORDER - THE ADDITIVE AND SUBTRACTIVE EFFECT OF THE 3 DOPAMINERGIC GENES - DRD2, D-BETA-H, AND DAT1, American journal of medical genetics, 67(3), 1996, pp. 264-288

Authors: COMINGS DE MUHLEMAN D GYSIN R
Citation: De. Comings et al., DOPAMINE D-2 RECEPTOR (DRD2) GENE AND SUSCEPTIBILITY TO POSTTRAUMATIC-STRESS-DISORDER - A STUDY AND REPLICATION, Biological psychiatry, 40(5), 1996, pp. 368-372

Authors: COMINGS DE MUHLEMAN D DIETZ G SHERMAN M FOREST GL
Citation: De. Comings et al., SEQUENCE OF HUMAN TRYPTOPHAN 2,3-DIOXYGENASE (TDO2) - PRESENCE OF A GLUCOCORTICOID RESPONSE-LIKE ELEMENT COMPOSED OF A GTT REPEAT AND AN INTRONIC CCCCT REPEAT, Genomics, 29(2), 1995, pp. 390-396

Authors: COMINGS DE GADE R MUHLEMAN D SVERD J
Citation: De. Comings et al., NO ASSOCIATION OF A TYROSINE-HYDROXYLASE GENE TETRANUCLEOTIDE REPEAT POLYMORPHISM IN AUTISM, TOURETTE SYNDROME, OR ADHD, Biological psychiatry, 37(7), 1995, pp. 484-486

Authors: COMINGS DE MACMURRAY J JOHNSON P DIETZ G MUHLEMAN D
Citation: De. Comings et al., DOPAMINE D2 RECEPTOR GENE (DRD2) HAPLOTYPES AND THE DEFENSE STYLE QUESTIONNAIRE IN SUBSTANCE-ABUSE, TOURETTE SYNDROME, AND CONTROLS, Biological psychiatry, 37(11), 1995, pp. 798-805

Authors: COMINGS DE WU S CHIU H RING RH AHN C MUHLEMAN D DIETZ G GADE R
Citation: De. Comings et al., POLYGENIC INHERITANCE AT A MOLECULAR-LEVEL - THE ADDITIVE EFFECT OF 3DOPAMINERGIC GENES IN TOURETTE SYNDROME, ADHD AND CONDUCT DISORDER, American journal of human genetics, 57(4), 1995, pp. 1372-1372

Authors: COMINGS DE MUHLEMAN D AHN C GYSIN R FLANAGAN SD
Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR GENE - A GENETIC RISK FACTOR IN SUBSTANCE-ABUSE, Drug and alcohol dependence, 34(3), 1994, pp. 175-180

Authors: COMINGS DE FLANAGAN SD DIETZ G MUHLEMAN D KNELL E GYSIN R
Citation: De. Comings et al., THE DOPAMINE-D(2) RECEPTOR (DRD2) AS A MAJOR GENE IN OBESITY AND HEIGHT, Biochemical medicine and metabolic biology, 50(2), 1993, pp. 176-185
Risultati: 1-25 | 26-27